Rock Liu

Since joining Golden Flag, Rock has been involved in the following:

• Edding Group Company Limited, an integrated biopharmaceutical company, in connection with a proposed merger and reverse takeover with Genor Biopharma Holdings Limited, a Hong Kong-listed biopharmaceutical company under Chapter 18A. The deal represents the first ever reverse takeover relating to a Chapter 18A listed company
• Goldman Sachs (Asia) L.L.C., Citigroup Global Markets Limited and J.P. Morgan Securities (Asia Pacific) Limited, in connection with the H-share placing of Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. The net proceeds from the H-Share Placing amounted to approximately HK$541.4 million
• ZG Group, a leading iron & steel e-commerce platform in China, on its business combination with Aquila Acquisition Corporation, a special purpose acquisition company. The negotiated value of ZG Group in this transaction is HK$10,004,000,000, and the committed PIPE investment as of the signing date is approximately HK$605 million. This is the first de-SPAC transaction in Hong Kong since the introduction of the SPAC listing regime in Hong Kong on 1 January 2022
• Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (HKSE: 6990) on its US$174 million global offering and listing on the The Stock Exchange of Hong Kong Limited on July 11, 2023
• The joint sponsors and underwriters on the global offering and listing of STAR CM Holdings Limited (HKSE: 6698) on the Main Board of the Stock Exchange of Hong Kong Limited on December 29, 2022. STAR CM is the largest variety program IP creator and operator in China in terms of revenue in 2021, owns and operates a large library of Chinese film IPs and is a music IP creator and operator in China

Prior to joining Golden Flag, Rock was involved in the following:

Healthcare

• Yunkang Group Limited (HKSE: 2325), a leading medical operation service provider in China that offers a full suite of diagnostic testing services for medical institutions, on its approximately US$140 million global offering and listing on The Stock Exchange of Hong Kong Limited
• Ocumension Therapeutics, in connection with its US$182.5 million IPO on the Main Board of HKEx. Ocumension Therapeutics, which started its business in 2017, is an ophthalmic pharmaceutical platform company dedicated to identifying, developing, and commercializing first or best-in-class ophthalmic therapies
• The underwriters and joint sponsors in the IPO and listing of Viva Biotech Holdings’ US$195 million IPO on the Main Board of HKEx. Viva Biotech Holdings is a leading open-access and innovation-driven technology platform company
• CanSino Biologics Inc., in connection with its US$161 million IPO and listing of H-Share on the Main Board of HKEx. CanSino Biologics Inc. is a bio-tech leader in research and development, manufacturing and commercialization of vaccine products for human use in China

Consumer & TMT

• BabyTree Group, in connection with its US$218 million IPO on the Main Board of HKEx. BabyTree Group is one of the largest and most active M&C-focused community-based platforms in China
• FingerTango Inc., in connection with its US$133 million IPO on the Main Board of HKEx. FingerTango Inc. is a leading mobile game publisher in China

Education

• The underwriters and sole sponsor in connection with the IPO of China Chunlai Education Group Co., Ltd listed on the Main Board of HKEx with a total offering amount of approximately US$80 million. China Chunlai Education Group Co., Ltd. is a leading provider of private higher education in China
• The underwriters and sole sponsor in the US$198 million IPO and listing of China YuHua Education Corporation Limited on the Main Board of HKEx. China YuHua Education Corporation Limited is the largest provider of private education from kindergarten to university in China

Other Industries

• The underwriters and joint sponsors in the IPO and listing of China Youran Dairy Group Limited on the HKEx with a total offering amount of approximately US$644 million. China Youran Dairy Group Limited is a leader in China’s upstream dairy market with an all-round business extending from breeding, feed to raw milk production
• Rizhao Port Jurong Co., Ltd., in connection with its US$70 million IPO and spin-off listing of H-Shares on the Main Board of HKEx. Rizhao Port Jurong Co., Ltd. is the largest port for grain and woodchip imports in China
• The underwriters and joint sponsors in the H-Share IPO and listing of Bank of Jiujiang Co., Ltd., on the HKEx with a total offering amount of approximately US$468 million. Bank of Jiujiang Co., Ltd. is a leading regional commercial bank in China
• The underwriters and joint sponsors in the IPO and listing of China Logistics Property Holdings Co., Ltd on the HKEx with a total offering amount of approximately US$434 million. China Logistics Property Holdings Co., Ltd is a leading provider of premium logistics facilities in China
• The underwriters and joint sponsors in the IPO and listing of Yadea Group Holdings Ltd. on the HKEx with a total offering amount of approximately US$166 million. Yadea Group Holdings Ltd. is a leading electric two-wheeled vehicle manufacturer in China